Literature DB >> 26890765

Increased Electron Paramagnetic Resonance Signal Correlates with Mitochondrial Dysfunction and Oxidative Stress in an Alzheimer's disease Mouse Brain.

Du Fang1, Zhihua Zhang2,1, Hang Li2, Qing Yu1,3, Justin T Douglas4, Anna Bratasz5, Periannan Kuppusamy6, Shirley ShiDu Yan1.   

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized clinically by cognitive decline and memory loss. The pathological features are amyloid-β peptide (Aβ) plaques and intracellular neurofibrillary tangles. Many studies have suggested that oxidative damage induced by reactive oxygen species (ROS) is an important mechanism for AD progression. Our recent study demonstrated that oxidative stress could further impair mitochondrial function. In the present study, we adopted a transgenic mouse model of AD (mAPP, overexpressing AβPP/Aβ in neurons) and performed redox measurements using in vivo electron paramagnetic resonance (EPR) imaging with methoxycarbamyl-proxyl (MCP) as a redox-sensitive probe for studying oxidative stress in an early stage of pathology in a transgenic AD mouse model. Through assessing oxidative stress, mitochondrial function and cognitive behaviors of mAPP mice at the age of 8-9 months, we found that oxidative stress and mitochondrial dysfunction appeared in the early onset of AD. Increased ROS levels were associated with defects of mitochondrial and cognitive dysfunction. Notably, the in vivo EPR method offers a unique way of assessing tissue oxidative stress in living animals under noninvasive conditions, and thus holds a potential for early diagnosis and monitoring the progression of AD.

Entities:  

Keywords:  Aβ accumulation; cognitive function; mitochondrial dysfunction; oxidative stress

Mesh:

Substances:

Year:  2016        PMID: 26890765      PMCID: PMC4839279          DOI: 10.3233/JAD-150917

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  67 in total

1.  Decreased proteolytic activity of the mitochondrial amyloid-β degrading enzyme, PreP peptidasome, in Alzheimer's disease brain mitochondria.

Authors:  Nyosha Alikhani; Lan Guo; Shiqiang Yan; Heng Du; Catarina Moreira Pinho; John Xi Chen; Elzbieta Glaser; Shirley ShiDu Yan
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

2.  Free radicals and superoxide dismutase in blood of patients with Alzheimer's disease and vascular dementia.

Authors:  Y Ihara; T Hayabara; K Sasaki; Y Fujisawa; R Kawada; T Yamamoto; Y Nakashima; S Yoshimune; M Kawai; M Kibata; S Kuroda
Journal:  J Neurol Sci       Date:  1997-12-09       Impact factor: 3.181

3.  High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation.

Authors:  L Mucke; E Masliah; G Q Yu; M Mallory; E M Rockenstein; G Tatsuno; K Hu; D Kholodenko; K Johnson-Wood; L McConlogue
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

4.  Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice.

Authors:  Lauren M Billings; Salvatore Oddo; Kim N Green; James L McGaugh; Frank M LaFerla
Journal:  Neuron       Date:  2005-03-03       Impact factor: 17.173

5.  Confirmation of superoxide generation via xanthine oxidase in streptozotocin-induced diabetic mice.

Authors:  Shingo Matsumoto; Ichiro Koshiishi; Toyoshi Inoguchi; Hajime Nawata; Hideo Utsumi
Journal:  Free Radic Res       Date:  2003-07

6.  Dynamic changes in the distribution and time course of blood-brain barrier-permeative nitroxides in the mouse head with EPR imaging: visualization of blood flow in a mouse model of ischemia.

Authors:  Miho C Emoto; Hideo Sato-Akaba; Hiroshi Hirata; Hirotada G Fujii
Journal:  Free Radic Biol Med       Date:  2014-07-08       Impact factor: 7.376

7.  Mitochondria dysfunction of Alzheimer's disease cybrids enhances Abeta toxicity.

Authors:  Sandra M Cardoso; Isabel Santana; Russell H Swerdlow; Catarina R Oliveira
Journal:  J Neurochem       Date:  2004-06       Impact factor: 5.372

Review 8.  The Alzheimer's disease mitochondrial cascade hypothesis: an update.

Authors:  Russell H Swerdlow; Shaharyar M Khan
Journal:  Exp Neurol       Date:  2009-01-29       Impact factor: 5.330

9.  Accelerating drug discovery for Alzheimer's disease: best practices for preclinical animal studies.

Authors:  Diana W Shineman; Guriqbal S Basi; Jennifer L Bizon; Carol A Colton; Barry D Greenberg; Beth A Hollister; John Lincecum; Gabrielle G Leblanc; Linda Bobbi H Lee; Feng Luo; Dave Morgan; Iva Morse; Lorenzo M Refolo; David R Riddell; Kimberly Scearce-Levie; Patrick Sweeney; Juha Yrjänheikki; Howard M Fillit
Journal:  Alzheimers Res Ther       Date:  2011-09-28       Impact factor: 6.982

10.  Feasibility and assessment of non-invasive in vivo redox status using electron paramagnetic resonance imaging.

Authors:  K-I Yamada; P Kuppusamy; S English; J Yoo; A Irie; S Subramanian; J B Mitchell; M C Krishna
Journal:  Acta Radiol       Date:  2002-07       Impact factor: 1.701

View more
  19 in total

1.  Mitochondrial Dysfunction Triggers Synaptic Deficits via Activation of p38 MAP Kinase Signaling in Differentiated Alzheimer's Disease Trans-Mitochondrial Cybrid Cells.

Authors:  Qing Yu; Fang Du; Justin T Douglas; Haiyang Yu; Shirley ShiDu Yan; Shi Fang Yan
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 2.  Cardiolipin in Central Nervous System Physiology and Pathology.

Authors:  Caitlin B Pointer; Andis Klegeris
Journal:  Cell Mol Neurobiol       Date:  2016-12-30       Impact factor: 5.046

3.  RAGE mediates Aβ accumulation in a mouse model of Alzheimer's disease via modulation of β- and γ-secretase activity.

Authors:  Fang Fang; Qing Yu; Ottavio Arancio; Doris Chen; Smruti S Gore; Shirley ShiDu Yan; Shi Fang Yan
Journal:  Hum Mol Genet       Date:  2018-03-15       Impact factor: 6.150

Review 4.  Mitochondrial Perturbation in Alzheimer's Disease and Diabetes.

Authors:  F Akhter; D Chen; S F Yan; S S Yan
Journal:  Prog Mol Biol Transl Sci       Date:  2017-02-04       Impact factor: 3.622

Review 5.  Mitochondria and Reactive Oxygen Species in Aging and Age-Related Diseases.

Authors:  Carlotta Giorgi; Saverio Marchi; Ines C M Simoes; Ziyu Ren; Giampaolo Morciano; Mariasole Perrone; Paulina Patalas-Krawczyk; Sabine Borchard; Paulina Jędrak; Karolina Pierzynowska; Jędrzej Szymański; David Q Wang; Piero Portincasa; Grzegorz Węgrzyn; Hans Zischka; Pawel Dobrzyn; Massimo Bonora; Jerzy Duszynski; Alessandro Rimessi; Agnieszka Karkucinska-Wieckowska; Agnieszka Dobrzyn; Gyorgy Szabadkai; Barbara Zavan; Paulo J Oliveira; Vilma A Sardao; Paolo Pinton; Mariusz R Wieckowski
Journal:  Int Rev Cell Mol Biol       Date:  2018-06-22       Impact factor: 6.813

6.  Antioxidants Rescue Mitochondrial Transport in Differentiated Alzheimer's Disease Trans-Mitochondrial Cybrid Cells.

Authors:  Qing Yu; Du Fang; Russell Howard Swerdlow; Haiyang Yu; John Xi Chen; Shirley ShiDu Yan
Journal:  J Alzheimers Dis       Date:  2016-09-06       Impact factor: 4.472

7.  Protective effects of reduced dynamin-related protein 1 against amyloid beta-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease.

Authors:  Maria Manczak; Ramesh Kandimalla; David Fry; Hiromi Sesaki; P Hemachandra Reddy
Journal:  Hum Mol Genet       Date:  2016-12-01       Impact factor: 6.150

8.  PINK1 signalling rescues amyloid pathology and mitochondrial dysfunction in Alzheimer's disease.

Authors:  Fang Du; Qing Yu; Shijun Yan; Gang Hu; Lih-Fen Lue; Douglas G Walker; Long Wu; Shi Fang Yan; Kim Tieu; Shirley ShiDu Yan
Journal:  Brain       Date:  2017-12-01       Impact factor: 13.501

9.  Orexin-A aggravates cytotoxicity and mitochondrial impairment in SH-SY5Y cells transfected with APPswe via p38 MAPK pathway.

Authors:  Maoyu Li; Yao Meng; Bingcong Chu; Yang Shen; Xiangtian Liu; Mao Ding; Chaoyuan Song; Xi Cao; Ping Wang; Linlin Xu; Yun Wang; Shunliang Xu; Jianzhong Bi; Zhaohong Xie
Journal:  Ann Transl Med       Date:  2020-01

10.  PINK1 Activation Attenuates Impaired Neuronal-Like Differentiation and Synaptogenesis and Mitochondrial Dysfunction in Alzheimer's Disease Trans-Mitochondrial Cybrid Cells.

Authors:  Fang Du; Qing Yu; Shirley ShiDu Yan
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.